{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:47:18Z","timestamp":1785775638556,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Emerg Radiol"],"DOI":"10.1007\/s10140-026-02480-4","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:53:21Z","timestamp":1777359201000},"page":"755-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Musculoskeletal imaging findings of xylazine-associated wounds"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-0655","authenticated-orcid":false,"given":"Alvaro A.","family":"Ordonez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-0957","authenticated-orcid":false,"given":"John D.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Bari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-0559","authenticated-orcid":false,"given":"Nogah","family":"Shabshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"24","key":"2480_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMp2303120","volume":"388","author":"R Gupta","year":"2023","unstructured":"Gupta R, Holtgrave DR, Ashburn MA (2023) Xylazine\u2014medical and public health imperatives. N Engl J Med 388(24):2209\u20132212","journal-title":"N Engl J Med"},{"issue":"22","key":"2480_CR2","doi-asserted-by":"publisher","first-page":"e183354","DOI":"10.1172\/JCI183354","volume":"134","author":"JR Trinko","year":"2024","unstructured":"Trinko JR, Foscue E, Kong EM, Basu A, Corstens AM, Thompson SL et al (2024) Xylazine induces dopamine release and augments the effects of fentanyl. J Clin Invest134(22):e183354","journal-title":"J Clin Invest"},{"issue":"1","key":"2480_CR3","doi-asserted-by":"publisher","first-page":"e2350630","DOI":"10.1001\/jamanetworkopen.2023.50630","volume":"7","author":"M Cano","year":"2024","unstructured":"Cano M, Daniulaityte R, Marsiglia F (2024) Xylazine in overdose deaths and forensic drug reports in US states, 2019\u20132022. JAMA Netw Open 7(1):e2350630","journal-title":"JAMA Netw Open"},{"key":"2480_CR4","doi-asserted-by":"crossref","unstructured":"Kariisa M, Patel P, Smith H, Bitting J (2021) Notes from the field: Xylazine detection and involvement in drug overdose deaths\u2014United States, 2019. MMWR Morb Mortal Wkly Rep. 2021;70(37):1300-1302","DOI":"10.15585\/mmwr.mm7037a4"},{"key":"2480_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109380","volume":"233","author":"J Friedman","year":"2022","unstructured":"Friedman J, Montero F, Bourgois P, Wahbi R, Dye D, Goodman-Meza D et al (2022) Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis. Drug Alcohol Depend 233:109380","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2480_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cll.2025.01.011","volume":"45","author":"KM Troike","year":"2025","unstructured":"Troike KM, McShane AJ (2025) Detecting xylazine: prevalence, pharmacokinetics, and analytical considerations. Clin Lab Med 45(2):283\u2013294","journal-title":"Clin Lab Med"},{"issue":"4","key":"2480_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","volume":"11","author":"SA Greene","year":"1988","unstructured":"Greene SA, Thurmon JC (1988) Xylazine \u2014 a review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Ther 11(4):295\u2013313","journal-title":"J Vet Pharmacol Ther"},{"key":"2480_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","volume":"240","author":"K Ruiz-Col\u00f3n","year":"2014","unstructured":"Ruiz-Col\u00f3n K, Chavez-Arias C, D\u00edaz-Alcal\u00e1 JE, Mart\u00ednez MA (2014) Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature. Forensic Sci Int 240:1\u20138","journal-title":"Forensic Sci Int"},{"issue":"10416","key":"2480_CR9","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(23)01686-0","volume":"402","author":"DT Zhu","year":"2023","unstructured":"Zhu DT, Friedman J, Bourgois P, Montero F, Tamang S (2023) The emerging fentanyl\u2013xylazine syndemic in the USA: challenges and future directions. Lancet 402(10416):1949\u20131952","journal-title":"Lancet"},{"issue":"7","key":"2480_CR10","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1097\/MS9.0000000000002190","volume":"86","author":"A Habib","year":"2024","unstructured":"Habib A, Ali T, Fatima L, Nazir Z, Hafiz AI, Haque MA (2024) Xylazine in illicit drug mixtures: a growing threat and overlooked danger. Ann Med Surg 86(7):3816\u20133819","journal-title":"Ann Med Surg"},{"issue":"5","key":"2480_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jhsg.2024.05.003","volume":"6","author":"R Tosti","year":"2024","unstructured":"Tosti R, Hozack BA, Tulipan JE, Criner-Woozley KT, Ilyas AM (2024) Xylazine-associated wounds of the upper extremity: evaluation and algorithmic surgical strategy. J Hand Surg Global Online 6(5):605\u2013609","journal-title":"J Hand Surg Global Online"},{"key":"2480_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104830","volume":"142","author":"D Ciccarone","year":"2025","unstructured":"Ciccarone D, Karandinos G, Krotulski A, Ondocsin J, Holm N, Montero F et al (2025) Tranq burn: exploring the etiology of xylazine-related soft tissue injuries. Int J Drug Policy 142:104830","journal-title":"Int J Drug Policy"},{"issue":"3","key":"2480_CR13","doi-asserted-by":"publisher","DOI":"10.1148\/rg.240249","volume":"45","author":"AA Ordonez","year":"2025","unstructured":"Ordonez AA, Sorin V, Miao JH, Karp JD (2025) Xylazine-associated musculoskeletal imaging findings. Radiographics 45(3):e240249","journal-title":"Radiographics"},{"issue":"1","key":"2480_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jamadermatol.2024.4253","volume":"161","author":"L Lutz","year":"2025","unstructured":"Lutz L, McFadden R, Xu L, Bhatia R, Davis MH, Rohacs N et al (2025) Wound characteristics among patients exposed to xylazine. JAMA Dermatol 161(1):75\u201380","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2480_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.annemergmed.2024.01.041","volume":"84","author":"J Perrone","year":"2024","unstructured":"Perrone J, Haroz R, D\u2019Orazio J, Gianotti G, Love J, Salzman M et al (2024) National Institute on Drug Abuse Clinical Trials Network meeting report: managing patients exposed to xylazine-adulterated opioids in emergency, hospital and addiction care settings. Ann Emerg Med 84(1):20\u201328","journal-title":"Ann Emerg Med"},{"issue":"1","key":"2480_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/10826084.2024.2409720","volume":"60","author":"MK Reed","year":"2025","unstructured":"Reed MK, Esteves Camacho T, Olson R, Grover Z, Rapoza T, Larson MJ (2025) Xylazine\u2019s impacts on the community in Philadelphia: perspectives of people who use opioids and harm reduction workers. Subst Use Misuse 60(1):100\u2013107","journal-title":"Subst Use Misuse"},{"issue":"2","key":"2480_CR17","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.jaad.2023.04.009","volume":"89","author":"A Bishnoi","year":"2023","unstructured":"Bishnoi A, Singh V, Khanna U, Vinay K (2023) Skin ulcerations caused by xylazine: a lesser-known entity. J Am Acad Dermatol 89(2):e99\u2013e102","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2480_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2106\/JBJS.24.00534","volume":"107","author":"SD Arango","year":"2025","unstructured":"Arango SD, Flynn JC, Zeitlin JH, Weir TB, Miller AJ (2025) Xylazine-associated necrotic upper-extremity wounds: a single hospital system\u2019s experience with 82 patients and 125 wounds. J Bone Joint Surg 107(3):279\u2013286","journal-title":"J Bone Joint Surg"},{"key":"2480_CR19","doi-asserted-by":"crossref","unstructured":"Robertson TF, Horn A, Smith FM, Huttenlocher A (2026) Evidence that xylazine disrupts skin homeostasis by acting on epithelial cells through the kappa opioid receptor. Dis Model Mech 19(3):dmm052600","DOI":"10.1242\/dmm.052600"},{"key":"2480_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.addicn.2024.100155","volume":"11","author":"ML Bedard","year":"2024","unstructured":"Bedard ML, Huang X-P, Murray JG, Nowlan AC, Conley SY, Mott SE et al (2024) Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism. Addict Neurosci 11:100155","journal-title":"Addict Neurosci"},{"issue":"3","key":"2480_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jhsa.2024.11.017","volume":"50","author":"P Johnsen","year":"2025","unstructured":"Johnsen P, Morway GR, Jackson A, Buchner SH, Gentile P, Ilyas AM et al (2025) The management of upper-extremity xylazine-associated wounds. J Hand Surg Am 50(3):331\u2013339","journal-title":"J Hand Surg Am"}],"container-title":["Emergency Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10140-026-02480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10140-026-02480-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10140-026-02480-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:03:15Z","timestamp":1785772995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10140-026-02480-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2480"],"URL":"https:\/\/doi.org\/10.1007\/s10140-026-02480-4","relation":{},"ISSN":["1438-1435"],"issn-type":[{"value":"1438-1435","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}